These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12895382)

  • 1. Randomized trials in oncology: a fertile ground for controversy.
    Markman M
    Curr Oncol Rep; 2003 Sep; 5(5):347-8. PubMed ID: 12895382
    [No Abstract]   [Full Text] [Related]  

  • 2. Looking for efficiency rather than efficacy in randomized controlled trials in oncology.
    Floriani I; Garattini S; Torri V
    Ann Oncol; 2010 Jul; 21(7):1391-1393. PubMed ID: 20501504
    [No Abstract]   [Full Text] [Related]  

  • 3. Stopping a trial early in oncology: for patients or for industry?
    Bradbury P; Meyer R; Pater J; Tu D; Seymour L; Shepherd L; Eisenhauer E
    Ann Oncol; 2009 Feb; 20(2):395-6. PubMed ID: 19150952
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase III trials in oncology: setting standards of care?
    Seeber S; Braun AH
    Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
    [No Abstract]   [Full Text] [Related]  

  • 5. Translational research in oncology comes timely.
    Chow LW; Toi M
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S263. PubMed ID: 16507388
    [No Abstract]   [Full Text] [Related]  

  • 6. Stopping a trial early in oncology: for patients or for industry?
    Whitehead J; Cobo E
    Ann Oncol; 2008 Aug; 19(8):1512-1513. PubMed ID: 18621741
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspective: The precision-oncology illusion.
    Prasad V
    Nature; 2016 Sep; 537(7619):S63. PubMed ID: 27602743
    [No Abstract]   [Full Text] [Related]  

  • 8. Early integration of palliative care into oncology: evidence, challenges and barriers.
    Zhi WI; Smith TJ
    Ann Palliat Med; 2015 Jul; 4(3):122-31. PubMed ID: 26231808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo effects in oncology.
    Chvetzoff G; Tannock IF
    J Natl Cancer Inst; 2003 Jan; 95(1):19-29. PubMed ID: 12509397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Reporting in Oncology Randomized Controlled Trials: From 2011 to 2015.
    Zhu H; Chen S; Xie P; Yang G; Zhong Z; Zhang H; Du Y
    Cancer Control; 2018; 25(1):1073274818781309. PubMed ID: 29895186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New designs for basket clinical trials in oncology.
    Simon R
    J Biopharm Stat; 2018; 28(2):245-255. PubMed ID: 28877003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trials in surgical oncology. Preface.
    Yopp AC; DeMatteo RP
    Surg Oncol Clin N Am; 2010 Jan; 19(1):xv-xvii. PubMed ID: 19914556
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized clinical trials in surgical oncology. Foreword.
    Petrelli NJ
    Surg Oncol Clin N Am; 2010 Jan; 19(1):xiii-xiv. PubMed ID: 19914554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Congress of the American Society of Clinical Oncology].
    André T
    J Chir (Paris); 2002 Oct; 139(5):300-3. PubMed ID: 12410132
    [No Abstract]   [Full Text] [Related]  

  • 15. Covariate-Adjusted Restricted Mean Survival Times and Curves.
    Eng KH; Seagle BL
    J Clin Oncol; 2017 Feb; 35(4):465-466. PubMed ID: 28129530
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
    Stewart DJ; Wheatley-Price P
    JAMA Oncol; 2021 Oct; 7(10):1577-1578. PubMed ID: 34436567
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
    Schindler TM; Marchington JM; Flores GV
    JAMA Oncol; 2021 Oct; 7(10):1578-1579. PubMed ID: 34436547
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
    Rizzo A; Mollica V; Massari F
    JAMA Oncol; 2021 Oct; 7(10):1577. PubMed ID: 34436578
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity-Reply.
    Del Paggio JC; Eisenhauer EA; Booth CM
    JAMA Oncol; 2021 Oct; 7(10):1579-1580. PubMed ID: 34436516
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis in hematology and oncology.
    Ioannidis JP; Schmid CH; Lau J
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):973-91. PubMed ID: 10949784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.